Staccato Alprazolam not checked
UCB Biopharma SRL · UCB7538
FollowEvery change as it happens, and a Monday email
Trials
2 active
4 in total · 2 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Route of administration: Inhalation Participants will receive one dose of Staccato alprazolam during the Treatment Period.”In the company’s words, NCT05077904 on ClinicalTrials.gov
- Tested for
- Stereotypical Prolonged Seizures (2 trials)
- Main trialPhase 3
- “The purpose of the study is to assess the success of a single administration of Staccato alprazolam compared with placebo both in rapidly terminating a seizure episode within 90 seconds and with no recurrence of seizure(s) up to 2 hours after investigational medicinal product (IMP) administration.”In the company’s words, NCT05077904 on ClinicalTrials.gov
- Other names
- UCB7538
Coming up2
- 29 Mar 2027Phase 3 trial completes · ClinicalTrials.gov
- 30 Nov 2028Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials4
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 29 Mar 2027 | A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures | |
| Phase 3Enrolling by invitation | 30 Nov 2028 | A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures | |
| Phase 1Completed | 24 Feb 2023 | A Relative Bioavailability Study of Staccato Alprazolam Versus Oral Alprazolam in Healthy Study Participants | |
| Phase 1Completed | 6 Jan 2026 | A Study to Assess the Time to Onset of Action of Staccato Alprazolam Versus Midazolam and Diazepam in Healthy Participants |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026